Rheumatoid arthritis, malignancy, and paraproteins.

C. Kelly,H. Sykes
DOI: https://doi.org/10.1136/ard.49.9.657
IF: 27.973
1990-09-01
Annals of the Rheumatic Diseases
Abstract:Rheumatoid arthritis and malignancy Mortality is increased in patients with rheumatoid arthritis (RA),' and large surveys of patients with reticuloses2 or RA3 have shown firm evidence of an association between lymphoma and RA. Further support for this association was also obtained from a large population study in Finland in 1982,4 where an excess of Hodgkin's disease, non-Hodgkin's lymphoma, myeloma, and leukaemia was shown in patients with RA. The association between lymphoma and RA seems to relate more to duration of disease than severity,5 with the mean interval between the onset ofRA and the development of lymphoma in one series being 17 years.6 The coexistence of RA and plasma cell dyscrasia was well recorded by Galli and Chiti in 1955,7 but they found some difficulty in separating the clinical features of each disorder. A relation between RA and myeloma was proposed in 1969 by Zawadzki and Benedek after a careful review of published work to which they were able to contribute six patients with both RA and a monoclonal gammopathy who had developed myeloma.8 At the same time an increased incidence ofRA among 112 unselected patients with plasma cell and lymphocytic neoplasms was reported,9 supporting the contention that the risk of plasma cell disorders is increased in patients with RA. A year later five further patients with longstanding RA who subsequently developed myeloma were reported.'0 Interestingly, it was noted that joint symptoms improved in each case after treatment with melphalan. A more recent study with more clearly defined diagnostic criteria has since confirmed the association between RA and myeloma. "
What problem does this paper attempt to address?